| Identification | Back Directory | [Name]
Furobufen | [CAS]
38873-55-1 | [Synonyms]
AY-21367
Furobufen
2-Dibenzofuranbutanoic acid
γ-Oxo-2-dibenzofuranbutanoic acid
2-Dibenzofuranbutanoic acid, γ-oxo- | [Molecular Formula]
C16H12O4 | [MDL Number]
MFCD00866025 | [MOL File]
38873-55-1.mol | [Molecular Weight]
268.27 |
| Chemical Properties | Back Directory | [Melting point ]
160.5-161 °C | [Boiling point ]
509.8±30.0 °C(Predicted) | [density ]
1.343±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 100 mg/mL (372.77 mM) | [form ]
Solid | [pka]
4.49±0.17(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
nti-inflammatory. | [in vivo]
Furobufen (po; 10, 30, 90 mg/kg; once daily; 7 days) produces a dose-related inhibition of the paw edema produced by carrageenan in male rats weighing 180-200 g[1]. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|